Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Volume  5 (2011)
Volume  4 (2010)
Volume  3 (2009)
Volume  2 (2008)
Volume  1 (2007)
Related articles

VOLUME 10 , ISSUE 3 ( July-September, 2016 ) > List of Articles

RESEARCH ARTICLE

Placenta Accreta: A Review of the Etiology, Diagnosis, and Management

Ivica Zalud, William Goh

Keywords : Accreta,Morbity adherent Placentation,Prenatal diagnosis

Citation Information : Zalud I, Goh W. Placenta Accreta: A Review of the Etiology, Diagnosis, and Management. Donald School J Ultrasound Obstet Gynecol 2016; 10 (3):352-363.

DOI: 10.5005/jp-journals-10009-1484

License: CC BY-NC 4.0

Published Online: 01-09-2017

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

How to cite this article

Goh W, Zalud I. Placenta Accreta: A Review of the Etiology, Diagnosis, and Management. Donald School J Ultrasound Obstet Gynecol 2016;10(3):352-363.

PDF Share
  1. Pregnancy related mortality in the United States, 1991-1997. Obstet Gynecol 2003;101: 289-297.
  2. Abnormal Placentation. Semin Perinatol 2009;33:88-96.
  3. Placenta Accreta and Postpartum Hemorrhage. Clin Ob/Gyn 2010;53(1):228-236.
  4. Obstet Gynecol 2002;99:169-170.
  5. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol 2010;115(1):65-69.
  6. Abnormal placentation: twenty year analysis. Am J Obstet Gynecol 2005;192:1458-1461.
  7. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997; 177:210-214.
  8. Placenta praevia and accreta: analysis of a two year experience. Gynecol Obstet Invest 1998;46:96-98.
  9. Maternal Morbidity Associated with Multiple Repeat Cesarean Deliveries. Obstet Gynecol 2006;107:1226-1232.
  10. The early sonographic appearance of placenta accreta. J Ultrasound Med 2003 Jan;22(1):19-23.
  11. Sonographic detection of placenta accreta in the second and third trimester. Am J Obstet Gynecol 2004;190(4):1135-1140.
  12. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med 2000;9(6):330-335.
  13. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 2009;33:193-203.
  14. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000;15:28-35.
  15. Placenta accreta: Evaluation with Color Doppler US, Power Doppler US, and MR Imaging. Radiology 1997;205:773-776.
  16. The value of specific MRI features in the evaluation of suspected placenta accreta. Magn Reson Imagin 2007;25(1):87-93.
  17. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 2006;108(3):573-581.
  18. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging. J Ultrasound Med 2008;27(9):1275-1281.
  19. Abnormal placental invasion-a novel approach to tdreatment. Ob Gyn Survey 2009;64(12):811-822.
  20. Placenta accreat/ percreta/increta: a cause of elevated maternal serum alphafetoprotein. Obstet Gynecol 1992;80(4):63-64.
  21. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1993;82(2):266-269.
  22. Risk factors for placenta accreta. Obstet Gynecol. 1999 Apr:93(4):545-550.
  23. Creatine kinase as a biochemical marker in diagnosis of placenta increta and percreta. Am J Obstet Gynecol. 1999 Apr;180(4):1039-1040.
  24. Increased cell-free fetal DNA in plasma of two women with Invasive Placenta. Clin Chem 2002;4(2):353-354.
  25. Increased level of cell-free placental mRNA in a subgroup of placentda previa. Prenat Diagn 2008;28(9):805-809.
  26. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta. Int J Gynecol Obstet 2010;109:30-33.
  27. Perinatal outcome of pregnancies complicated by placenta accreta. Obstet Gynecol 2004;104(3):527-530.
  28. Peripartum hysterectomy: 1999 to 2006. Obstet Gynecol 2008; 111(3):732-738.
  29. Optimal management strategies for placenta accreta. BJOG 2009;116(5):648-654.
  30. Emergency postpartum hemorrhage for uncontrolled postpartum bleeding. Obstet Gynecol 2010;115(3):637-644.
  31. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol 2004;104(3):531-536.
  32. Reilly J, Moretti M, Pillari V. Argon beam coagulation in the management of placenta accreta. Obstet Gynecol 1999;94(2):825-827.
  33. B-Lynch suture, intrauterine ballon, and endouterine hemostatic suture for the management of postpartum hemorrhage due to placenta previa accreta. Int J Gynecol Obstet 2010;108(3):191-193.
  34. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010;115(3):526-534.
  35. Management of placenta accreta: morbidity and outcome. Eur J Obstet Gynecol Reprod Biol 2007;133(1):34-39.
  36. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv 2007;62(8):529-539.
  37. Predictors of failed pelvic arterial embolization for severe postpartum hemorrhage. Obstet Gynecol 2009;113(5):992-999.
  38. Fertility and obstetric outcome after conservative management of placenta accreta. Int J Gynecol Obstet 2010:109(2):147-150.
  39. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol 2010;202(1):28:e1-9.
  40. Anaesthetic management of placenta accreta: use of a pre-operative high and low suspicioun classification. Anaesthesia 2005;60:1079-1084.
  41. Anesthesia for the repeat cesarean section in the parturient with abnormal placentation: what does an obstetrician need to know? Arch Gynecol Obstet 2006;273(6): 319-321.
  42. Placenta percreta and the Urologist. Rev Urol 2009;11(3):173-176.
  43. Pathology of the human placenta. New York; Springer-Verlag 2006.
  44. Placental basal plate formation is associated with fibrin deposition in decidual veins at sites of trophoblastic cell invasion. Am J Obstet Gyneceol 2002;186(2):291-296.
  45. Occult Placenta Accreta: the missing link in the diagnosis of abnormal placentation. Ped Dev Path 2007;10:266-277.
  46. Placenta accreta: an immunohistologic study of trophoblast populations. Placenta. 1987 May-Jum;8(3):273-282.
  47. Differential Expression of Growth-, Angiogenesis- and Invasion-related Factors in the Development of Placenta Accreta. Taiwanese J Obstet Gynecol 2006;45(2): 100-105.
  48. Expression of epideral growth factor receptor and c-erbB-2 oncoprotein in trophoblast populations of placenta accreta. Am J Obstet Gynecol 2004;191: 2106-2113.
  49. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placaenta accreta. Placenta 2006;27:70-78.
  50. Differential expression of angiopoietin-1, angiopoietin-2 and Tie receptors in placentas from pregnancies complicated by placenta accreta. Am J Obstet Gynecol 2006;194:564-571.
  51. Metalloproteinases and human placenta invasiveness. Placenta 2006;27:783-793.
  52. Marix metalloproteinases-2, -3 and -9 in human term placenta. Acta histochemica 2007;109:403-412.
  53. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2004;2:59.
  54. Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: a role for IFN-gamma. J Immunol 2006;15:177(12):8522-8530.
  55. Human decidual relaxin and preterm birth. Ann. N Y Acad Sci 2005;1041:338-344.
  56. Early placental insulinlike protein (INSL4 or EPIL) in placental and fetal membrane growth. Biol Reprod 2005;73:695-702.
  57. Relaxin, its receptor (RXFP1), and insulin-like peptide 4 expression through gestation and in placenta accreta. Reprod Sci 2013;20(8):968-980.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.